Effects of arsenic trioxide on expressions of vascular endothelial growth factor and P-glycoprotein in multidrug resistant leukemia cell line K562/A02

Journal of Chinese Integrative Medicine

Volumn 5, Issue 6, 2007, Pages 647-650

  Liang, Hong ^a   Zhang, Yu ^a   Zhang, Jian Dong ^a   Gu, Jian ^b   Ma, Li ^b   Wang, Xiao Ling ^b   Shen, Wei Gan ^a  

^a YANGZHOU UNIVERSITY   (China)

^b Yangzhou Institute of Technology   (China)

Author keywords

Arsenic compounds; Endothelial growth factors; Leukemia; Vascular endothelium

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ARSENIC TRIOXIDE; GLYCOPROTEIN P; VASCULOTROPIN;

ARTICLE; CELL STRAIN K 562; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INCUBATION TIME; MITOSIS INHIBITION; MULTIDRUG RESISTANCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION;

ANTINEOPLASTIC AGENTS; ARSENICALS; CELL PROLIFERATION; DOWN-REGULATION; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; K562 CELLS; OXIDES; P-GLYCOPROTEIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 36549001290     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20070609     Document Type: Article

References (11)

1. Chen XY, Liu JT. Study on tumor cells' multidrug resistance and its reversion by Chinese herbs. Zhong Xi Yi Jie He Xue Bao. 2003; 1(3): 221-225. Chinese with abstract in English.
2. Dias S, Shmelkov SV, Lam G, et al. VEGF (165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition. Blood. 2002; 99(7): 2532-2540.
3. Lu XY, Li QS, Feng WJ. The expression of P-gp and VEGF in non-small cell lung cancer. Lin Chuang Fei Ke Za Zhi. 2003; 8(4): 304-306. Chinese with abstract in English.
4. Malmer B, Brännström T, Andersson U, et al. Does a low frequency of P53 and Pgp expression in familial glioma compared to sporadic controls indicate biological differences? Anticancer Res. 2002; 22(6): 3949-3954.
5. Koomägi R, Mattern J, Volm M. Up-regulation of resistance-related proteins in human lung tumors with poor vascularization. Carcinogenesis. 1995; 16(9): 2129-2133.
6. Volm M, Koomägi R, Mattern J, et al. Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro. Anticancer Res. 1997; 17(1): 99-103.
7. Klement G, Huang P, Mayer B, et al. Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts. Clin Cancer Res. 2002; 8(1): 221-232.
8. Huang XR, Qi MX, Wu ZZ, et al. The inhibition of Rhizoma Curcumae and arsenite trioxide on proliferation of lens epithelial cell by detection of proliferating cell nuclear antigen. Zhonghua Zhong Yi Yao Xue Kan. 2007; 25(2): 201-203. Chinese with abstract in English.
9. Guo ZM, Xie ZX, Qin Y. Relationship between VEGF and MDR in acute leukemia patients. Zhongguo Xian Dai Yi Xue Za Zhi. 2004; 14(5): 121-123. Chinese with abstract in English.
10. 562/ADM cell line. Jie Pou Ke Xue Jin Zhan. 2002; 8(3): 237-239. Chinese with abstract in English.
11. Li XM, Han JQ. Expression of VEGF and MDR1 in acute myeloid leukemia patients and the relation with prognosis. Xian Dai Zhong Liu Yi Xue. 2006; 14(2): 215-217. Chinese with abstract in English.